Center-Authored Papers

Filters: Keyword is Neoplasms, Hormone-Dependent  [Clear All Filters]
F
Fang M, Toher J, Morgan M, Davison J, Tannenbaum S, Claffey K.  2011.  Genomic differences between estrogen receptor (ER)-positive and ER-negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis.. Cancer. 117(10):2024-34. Abstract
G
Glover CE, Gurley KE, Kim K-H, Storer BE, Fero ML, Kemp CJ.  2009.  Endocrine dysfunction in p27Kip1 deficient mice and susceptibility to Wnt-1 driven breast cancer.. Carcinogenesis. 30(6):1058-63. Abstract
H
Herold CI, Djulbegovic B, Hozo I, Lyman GH.  2010.  Reliable data on 5- and 10-year survival provide accurate estimates of 15-year survival in estrogen receptor-positive early-stage breast cancer.. Breast cancer research and treatment. 121(3):771-6. Abstract
L
Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O'Sullivan MJ, Wactawski-Wende J, Yasmeen S et al..  2010.  Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.. Journal of the National Cancer Institute. 102(18):1422-31. Abstract
M
Mendiratta P, Mostaghel EA, Guinney J, Tewari AK, Porrello A, Barry WT, Nelson PS, Febbo PG.  2009.  Genomic strategy for targeting therapy in castration-resistant prostate cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(12):2022-9. Abstract
Moinpour CM, Donaldson GW, Nakamura Y.  2009.  Chemotherapeutic impact on pain and global health-related quality of life in hormone-refractory prostate cancer: Dynamically Modified Outcomes (DYNAMO) analysis of a randomized controlled trial.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 18(2):147-55. Abstract
Montgomery BR, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, True LD, Nelson PS.  2008.  Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.. Cancer research. 68(11):4447-54. Abstract
P
Phipps AI, Malone KE, Porter PL, Daling JR, Li CI.  2008.  Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer.. Cancer. 113(7):1521-6. Abstract
Phipps AI, Malone KE, Porter PL, Daling JR, Li CI.  2008.  Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(8):2078-86. Abstract
W
Wang D, Montgomery BR, Schmidt LJ, Mostaghel EA, Huang H, Nelson PS, Tindall DJ.  2009.  Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression.. Cancer research. 69(24):9448-56. Abstract